- Home
- ZLAB vs AVAH Comparison
ZLAB vs AVAH Comparison
Compare ZLAB & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZLAB | AVAH |
|---|---|---|
| Founded | 2013 | 1984 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZLAB | AVAH |
|---|---|---|
| Price | $19.20 | $7.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 9 |
| Target Price | ★ $51.52 | $10.56 |
| AVG Volume (30 Days) | 600.7K | ★ 1.0M |
| Earning Date | 05-29-2026 | 04-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.46 | ★ 91.55 |
| EPS | N/A | ★ 0.22 |
| Revenue | $460,156,000.00 | ★ $2,024,506,000.00 |
| Revenue This Year | $19.06 | $21.81 |
| Revenue Next Year | $18.58 | $5.96 |
| P/E Ratio | ★ N/A | $32.73 |
| Revenue Growth | ★ 15.33 | 6.82 |
| 52 Week Low | $15.96 | $3.67 |
| 52 Week High | $44.34 | $10.32 |
Technical Indicators
Market Signals| Indicator | ZLAB | AVAH |
|---|---|---|
| Relative Strength Index (RSI) | 52.53 | 38.00 |
| Support Level | $17.00 | $3.81 |
| Resistance Level | $19.70 | $8.54 |
| Average True Range (ATR) | 0.72 | 0.30 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 59.77 | 30.37 |
Price Performance
Historical ComparisonAbout ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.